SV Health Investors’ Dementia Discovery Fund Announces $269M Final Close of DDF-2

Contributed by: Business Wire

Logo

Tags

Science

Neurology

Research

Finance

General Health

Health

Mental Health

Professional Services

DDF-2

More Like This

“I have real hope that Britain can come together to defeat dementia" – PM

Alzheimer's Drug Discovery Foundation and Harrington Discovery Institute Center for Brain Health Medicines Invite Proposals for 2024 ADDF-Harrington Scholar Award

MULTI-MILLION POUND BOOST FOR RESEARCH PROJECTS AIMED AT DEVELOPING NEW TESTS, TREATMENTS AND DEVICES FOR NEURODEGENERATIVE DISEASES

EQT Life Sciences co-leads EUR 51 million Series B in Exciva to advance its Alzheimer's therapy into clinical Phase 2

Advances in science set to transform treatments for people living with dementia

Edward Kliphuis, Partner, Sofinnova Digital Medicine Strategy and Simon Turner, Partner, Sofinnova Digital Medicine Strategy (Photo: Sofinnova Partners)

Sofinnova Partners Raises $200M Digital Medicine Fund

BD² Expands Foundational Effort to Understand Biology of Bipolar Disorder with $36 Million in New Grants

"Disrupt" introduces Disrupt Health Impact Fund with leading business groups in Thailand to invest in HealthTech startups globally